Home › Islet Cell Adenoma › Missouri › St. Louis
Islet Cell Adenoma clinical trials in St. Louis, MO
5 studies for Islet Cell Adenoma are looking for participants at sites in and around St. Louis (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
RecruitingPhase 2/3
- Siteman Cancer Center, St Louis
Study of RYZ401 in Subjects With Solid Tumors Expressing SSTRs.
RecruitingPhase 1
- Research Facility, St Louis
- Research Facility, St Louis
Testing the Addition of Sunitinib Malate to Lutetium Lu 177 Dotatate (Lutathera) in Pancreatic Neuroendocrine Tumors
RecruitingPhase 1
- Washington University School of Medicine, St Louis
- Siteman Cancer Center-South County, St Louis
- Siteman Cancer Center at Christian Hospital, St Louis
- and 2 more
Study of RYZ101 Compared With SOC in Pts w Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 177Lu-SSA Therapy
RecruitingPhase 3
- Research Facility, St Louis
Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors
RecruitingPhase 2
- Mercy Infusion Center - Chippewa, St Louis
- Washington University School of Medicine, St Louis
- Mercy Hospital South, St Louis
- and 6 more
Islet Cell Adenoma trials in other cities
- Rochester, MN5 studies
- Los Angeles, CA5 studies
- Phoenix, AZ4 studies
- Washington, DC4 studies
- Salt Lake City, UT4 studies
- Portland, OR4 studies
- Columbus, OH4 studies
- Lexington, KY4 studies
- Chicago, IL4 studies
- Jacksonville, FL3 studies
- Irvine, CA3 studies
- Philadelphia, PA3 studies
Other studies in St. Louis
- Non-Small Cell Lung Cancer73 studies
- Breast Cancer64 studies
- Metastatic Cancer54 studies
- Colorectal Cancer50 studies
- Prostate Cancer46 studies
- Cancer (all types)46 studies
- Lung Cancer39 studies
- Ovarian Cancer38 studies
- Pancreatic Cancer33 studies
- Endometrial Cancer29 studies
- Head and Neck Squamous Cell Carcinoma28 studies
- Heart Failure26 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.